Organisation paid for research Program year 2023 Source: CMS Open Payments

Clinical Research Solutions, LLC

Neither a doctor nor a teaching hospital

Research payments

$267,625

44 payments

Through program year 2023, Clinical Research Solutions, LLC is reported as receiving $267,625 in research payments, across 44 payments.

By program year

4 rows

Year	Kind	Amount	Payments
2023	Research	$455	1
2022	Research	$20,582	7
2021	Research	$193,106	18
2019	Research	$53,482	18

Breakdown

Who paid Research payments · program years 2019–2023

Sekisui Diagnostics LLC $167,254 1 payment
Vanda Pharmaceuticals Inc. $46,982 12 payments
Urogen Pharma, Inc. $32,414 21 payments
Avanir Pharmaceuticals, Inc. $14,475 4 payments
Kowa Research Institute, Inc. $3,500 3 payments
Chiesi USA, Inc. $3,000 3 payments

Studies the money was for Research payments · program years 2019–2023

Acucy SARS-CoV-2 Antigen Test $167,254 1 payment
Study to Assess the Efficacy of VLY-686 in Relieving Symptoms of Gastroparesis $23,882 8 payments
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study to Assess the Efficacy of Tradipitant in Relieving Symptoms of Gastroparesis $23,100 4 payments
Urogen Bl-006 $15,100 6 payments
Ur001 $15,000 2 payments
20-Avp-786-306 $14,475 4 payments
K-877-303 $3,500 3 payments
Ccd-05993Aa3-01 $3,000 3 payments
Urogen Bl006 $1,152 10 payments
Urogen Pharma Bl011 $707 2 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.